NOTE 8 ACCRUED OTHER EXPENSES
Accrued other expenses consisted of the following amounts (in thousands):
As of September 30,
As of December 31,
2026
2025
Accrued research and development costs
$
4,903
7,161
Deferred income – transition services agreement (TSA) performance obligation, current portion
5,180
—
Accrued other
5,653
759
Total accrued other expenses
15,736
7,920
The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period.
Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 720 -SubTopic 30 -Name Accounting Standards Codification -Section 45 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483384/720-30-45-1
No definition available.